CRCT & Schering has sued Accord Healthcare Temodar


Cancer Research Technology Limited & Schering has sued Accord Healthcare on US Patent 5260291. Product: Temodar Capsule (Temozolomide).

Note: Teva is the first to file ANDA holder. In the Paragraph litigation district court had held ‘291 patent invalid due to prosecution latches and inequitable conduct. Schering appealed this decision and CAFC had reversed the district court finding on prosecution latches and inequitable conduct. Meanwhile , Teva entered settlement with Schering as Teva will not commence marketing generic version till Federal court decision and Teva will commence marketing generic version after expiry of ‘291 Aug 2013, but before expiry of Pediatric exclusivity.

Now after Federal court decision upholding ‘291 patent validity, Schering has sued Accord healthcare the subsequent ANDA filler for Temodar.

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Patent case and tagged , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s